You are visiting us from Virginia. You are located in HHS Region 3. Your Center is Central East ATTC.

Share Your Perspectives about Opioid Use Disorder among People with Disabilities from Minority Backgrounds


Share Your Perspectives about Opioid Use Disorder among People with Disabilities from Minority Backgrounds.Please click or cut and paste survey link below to participate:

https://www.psychdata.com/s.asp?SID=189204

We are pleased to invite substance, mental health service and vocational rehabilitation professionals (e.g., counselors, clinicians, directors) from across the country that provide to participate in a national study on Opioid Use Disorder Impacts on Employment Prospects for People with Disabilities from minority backgrounds (i.e., African American, Hispanic or Latino, American Indian, Alaskan Native, or Native Hawaiian or other Pacific Islanders). Opioid use disorder (OUD) can involve maladaptive/misuse of prescribed opioid medications, use of diverted opioid medications, or use of illicitly obtained heroin.

This study is being conducted by The Langston University Rehabilitation Research and Training Center (LU-RRTC) on Research and Capacity Building for Minority Entities. Langston University is the only historically black college or university (HBCU). The LU-RRTC is funded by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR).

The new information generated through this study would provide insights on how policy makers, educators and federal research sponsoring agencies such as the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) and the National Institutes of Health (NIH) can better respond to the needs of people with opioid use disorder, especially people with disabilities from minority backgrounds. In addition, the study findings may be used as a foundation for developing interventions that seek to improve the experiences and outcomes of individuals with disabilities from minority backgrounds with opioid use disorder.

The information in this study will be used only for research purposes and in ways that will not reveal who you are. Study participants will not be identified in any publication from this study. The survey will take around 20 minutes to complete. If you have any questions or concerns, please contact Dr. Corey Moore (Principal Investigator) via email: [email protected] or Dr. Edward Manyibe (Co-PI) via email: [email protected]. If you experience technical difficulty with the survey, contact Dr. Andre Washington: [email protected] and he will be happy to assist you.

Please click or cut and paste survey link below to participate:

https://www.psychdata.com/s.asp?SID=189204

Thank you in advance for your contribution.

Published:
06/10/2020
Tags
Recent posts
How a Prevention Coalition Used NIATx to Boost Parent Participation in Prevention Efforts
Prevention coalitions often face challenges engaging parents in prevention initiatives, even when those efforts address critical issues like youth substance use or mental health. Here's an example of how a fictional coalition decided to take on this challenge by using the NIATx Plan-Do-Study-Act (PDSA) tool. The small, incremental changes they made helped to increase attendance […]
Flowcharting: The Foundation for Making Meaningful Improvements
The flowchart is one of the essential tools in the NIATx model. A flowchart provides visual map of your process—it shows how things get done, step by step. You might be thinking, “Why do we need a flowchart if we already did a walk-through of the process?" If the process seems straightforward, your team might […]
Need more info on Xylazine, Nitazenes and Medetomidine? Opioid Response Network is crowdsourcing info on all three
Xylazine, medetomidine and nitazines are substances that are emerging as key contributors in the latest wave of the Opioid Overdose Epidemic. Xylazine is an adulterant that increases the duration of a user’s fentanyl high and delays withdrawal to some extent. Medetomidine is another adulterant that belongs to the same family of drugs as xylazine, but […]
The Ripple Effect: How Small Changes Make a Big Impact - A Look Inside the Milwaukee Comprehensive Care Initiative (MC3) and NIATx Learning Collaborative
The NIATx model was designed to be easily adopted and sustained by organizations and systems without the need for ongoing consultation or complicated processes. It's built to empower teams to identify and make small changes that lead to big improvements. Milwaukee County's behavioral health system first got involved with NIATx in 2011. Since then, NIATx […]

The opinions expressed herein are the views of the authors and do not reflect the official position of the Department of Health and Human Services (DHHS), SAMHSA, CSAT or the ATTC Network. No official support or endorsement of DHHS, SAMHSA, or CSAT for the opinions of authors presented in this e-publication is intended or should be inferred.

Copyright © 2025 Addiction Technology Transfer Center (ATTC) Network
map-markermagnifiercrossmenuchevron-down